Navigation Links
X-Change Corporation Launches Upgraded Version of Phytiva Website, As Company Targets Distribution of Phytiva Product Line in United States and Worldwide, Extracts and New Products in Europe
Date:5/15/2013

DALLAS, May 15, 2013 /PRNewswire/ -- X-Change Corp. (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health solutions through its Phytiva brand product lines is excited to announce the launch of its new website at www.phytiva.com.  The website's design has been upgraded for a more interesting and effective viewing experience and a powerful Patient Resource Center for sharing of critical information.  The Company launches the new website as it targets distribution of the Phytiva product line in the U.S. and worldwide, while preparing the release of extracts and other new products in the European market.

The upgraded website will allow X-Change Corp to focus on targeted markets in a more efficient manner both geographically and ailment-specific.  The geographical markets include Europe, Asia, Australia, and the United States and Canada.  Ailments initially targeted include arthritis, AIDS/HIV, Alzheimer's, general anti-aging, asthma, autism, cancer, chronic pain management, diabetes, digestive diseases, glaucoma, high blood pressure, influenza, multiple sclerosis, and PTSD.

The premier upgrade to the website is the "Patient Resource Center".  The Patient Resource Center will be utilized by our customers to share information about themselves and also about their experiences with cannabinoid-based products.  This platform will allow substantial exchange of information and experience to not only better inform patients but also to provide the Company with a real time connection to data that may be rapidly translated into improved products and development of new and needed solutions, all at an ever more competitive price for customers.

Moreover, patients, caregivers, doctors, and other Center-registered users can visit this area of the website to share their experiences with cannabinoid treatments and track their progress. With this new technology, for example, medical cannabis patients will be able to join a secure, web-based, information-sharing community.  Using a username and password, patients will have the ability to login and record their daily progress, while they self-administer their cannabinoid treatments.  Patients will also have the ability to add pictures or videos to demonstrate visually the progress of their treatments. 

Immediately, the website will provide for pre-registration for the Patient Resource Center while the Center is under final-stage development.  The website also features the stories of four patients who have opted to self-administer cannabinoid-based oils to treat their squamous and basal cell carcinomas, with picture evidence of the apparent eradication of these lesions.

In the future, the website will also include an online store for the purchase of over the counter nutraceutical and cosmeceutical product lines. As always, press releases and breaking news are still viewable on the site, as well as information for investors and profiles of the management team's members.

About Phytiva

Phytiva is the newly launched brand that is a hybrid of a proven, existing product line that has been well-managed and conservatively-run for over a decade with a hemp-based product line, utilizing the unique and potent benefits of the hemp plant. Phytiva's revolutionary formulations target not just the symptom, but also the cause.  Hemp is the ideal basis for healing solutions and has been utilized for centuries, as skin responds extremely well to its properties.

Phytiva strives to be one of the quintessential cosmeceutical and nutraceutical brands in the world. As cosmetics and nutrition are personal, over-the-counter markets, they continuously evolve with the introduction of new formulations and products, creating a multibillion-dollar global market.  The Company believes that Phytiva will capture a substantial and highly profitable portion of that market, as Phytiva becomes a household name.

About The X-Change Corporation

X-Change Corp is U.S. Boutique Company whose niche is cannabinoid based extracts and product lines that target critical ailments through State-by-State and International regulatory guidelines, the cosmeceutical/nutraceutical market for mid-tier product lines, such as Phytiva, and new social usage initiatives. These product lines will be launched through a combination of retail and wholesale outlets, medical cannabis dispensaries, cannabis research/treatment clinics, laboratories, and other government regulated distribution channels on a jurisdictional basis internationally.

Forward Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. X-Change Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

X-Change Corp.
President & CEO
Robert Kane

info@phytiva.com
www.phytiva.com
1.866.326.5595


'/>"/>
SOURCE X-Change Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cempra, Inc. Signs Exclusive License and Development Agreement for Solithromycin with Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings Corporation in Japan
2. Healthcare Corporation of America Sets Date for Release of its First-Quarter Results and Conference Call
3. Comprehensive Care Corporation Announces Pharmacy Savings Management Agreement With Utica City School District
4. Omeros Corporation Reports First Quarter 2013 Financial Results
5. Heska Corporation to Present at the 14th Annual B. Riley & Co. Investor Conference
6. Sigma-Aldrich Corporation Declares $0.215 Per Share Quarterly Dividend
7. Luminex Corporation To Present At Upcoming Investment Conferences
8. Celladon Corporation is a Finalist for the 2013 Red Herring Top 100 North America Award
9. Henry Schein Named As One Of FORTUNEs Largest 300 Corporations In America
10. Kinex Pharmaceuticals and Zenith Technology Corporation announce the execution of a collaborative licensing agreement
11. Heska Corporation to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... and Markets has announced the addition of the "Vital Signs Monitoring ... Industry Forecast, 2014-2022" report to their offering. ... Vital signs monitoring market size was worth $3,694 ... growing at a CAGR of 5.8% from 2016 to 2022. ... in global vital signs monitoring devices industry. The blood pressure monitoring devices ...
(Date:1/18/2017)... SAN JOSE, Calif. , Jan. 18, 2017  Adaptive ... machines, announced today a new partnership with Hyatt Place ... guests by providing ASTI LectroFan sleep therapy machines in ... "Obviously one of the most important parts of having ... Wicks , general manager of Hyatt Place Nashville/Downtown. "We,re ...
(Date:1/18/2017)... LITTLE FALLS, N.J. , Jan. 18, 2017 /PRNewswire/ ... RGIN ), a biotechnology company specializing in the development ... health of damaged tissues and organs, recently reported the ... key milestones for 2017. As the Company ... 2016 has been a year of substantial accomplishments. The ...
Breaking Medicine Technology:
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... in a medical capacity this year. Drs. Alexander Paziotopoulos, Andrew Petersen and Trish ... a condensed version of the clinic’s leading recovery program. , “We know ...
(Date:1/19/2017)... ... 19, 2017 , ... Bio-Optronics Inc. is proud to announce ... designed to seamlessly integrate and streamline the way researchers prepare and conduct patient ... usability and improving efficiency significantly for users – a first in the CTMS ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... panel system. , The Tranquility privacy panel system was designed to deliver ... Tranquility panels help reduce noise and provide the visual privacy required to maintain ...
(Date:1/19/2017)... ... January 19, 2017 , ... Rountree ... planning services to communities throughout eastern Georgia, is embarking on a charity effort ... Heart disease kills more Americans every year than anything else, yet risk factors ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Attorney Robert ... fifth consecutive year donated money to the Triumph Over Kid Cancer foundation. Each year, ... one of those children. James saw firsthand the effect of the critical funding gap ...
Breaking Medicine News(10 mins):